Eric Harris

Eric Harris is an experienced professional in commercial analytics and forecasting, currently serving as the Director of Commercial Analytics & Forecasting at Neurocrine Biosciences since January 2019. Prior roles include Director of Business Analytics & Insights at Theravance Biopharma, where revenue potential for launched and developmental products was forecasted, and various positions at Janssen Pharmaceuticals, focusing on new business development across Latin America and oncology analytics. Earlier experience includes finance management positions at DePuy Orthopaedics and Advanced Sterilization Products, as well as consulting roles that drove significant improvements in business processes. Eric holds an MBA in Corporate Finance and Marketing from Indiana University and a Bachelor’s degree in Industrial & Systems Engineering from Georgia Institute of Technology.